Viewing Study NCT01011166


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-03-10 @ 9:47 PM
Study NCT ID: NCT01011166
Status: COMPLETED
Last Update Posted: 2015-04-23
First Post: 2009-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module